|
Overall baricitinib group (N = 106)
|
74 (76)
|
76 (76)
|
47 (47)
|
73 (73)
|
|
Concomitant corticosteroids
|
|
Yes (N = 31)
|
27 (87)
|
26 (84)
|
14 (45)
|
20 (65)
|
|
No (N = 72)
|
47 (70)
|
50 (72)
|
33 (48)
|
53 (77)
|
|
Age group
|
|
Patients < 65 years (N = 80)
|
61 (81)
|
66 (86)
|
40 (52)
|
58 (75)
|
|
Patients ≥ 65 years (N = 23)
|
13 (57)
|
10 (43)
|
7 (30)
|
15 (65)
|
|
SDAI prior to vaccination
|
|
≤ 3.3 (N = 21)
|
14 (70)
|
16 (76)
|
11 (52)
|
16 (76)
|
|
> 3.3 and ≤ 11 (N = 47)
|
36 (82)
|
34 (76)
|
24 (53)
|
29 (64)
|
|
> 11 (N = 32)
|
23 (74)
|
25 (81)
|
11 (35)
|
26 (84)
|
|
Dose
|
|
2 mg (N = 16)
|
11 (73)
|
11 (73)
|
9 (60)
|
9 (60)
|
|
4 mg (N = 87)
|
63 (76)
|
65 (76)
|
38 (45)
|
64 (75)
|
